lapatinib (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
lapatinib
Lapatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lapatinib/Lapatinib/pm42248878-309-46-51
Average 94 stars, based on 36 article reviews
Lapatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lapatinib/Lapatinib/pm42248878-309-46-51
Average 94 stars, based on 36 article reviews
lapatinib - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
Concentration Assay:Article Title: A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer Article Snippet: Garadacimab (GD, Cat# HY-P99631), Microarray:Article Title: A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer Article Snippet: Garadacimab (GD, Cat# HY-P99631), Western Blot:Article Title: A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer Article Snippet: Garadacimab (GD, Cat# HY-P99631), Solvent:Article Title: A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer Article Snippet: Garadacimab (GD, Cat# HY-P99631), Phospho-proteomics:Article Title: A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer Article Snippet: Garadacimab (GD, Cat# HY-P99631), Control:Article Title: A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer Article Snippet: Garadacimab (GD, Cat# HY-P99631), |